UBE Corporation · TSE:4208

UBE — Ube Industries — FY2013 Earnings Presentation

28 slides from UBE's earnings presentation, May 12, 2014

  1. Slide 1: FY2013 Consolidated Results, FY2014 Consolidated Forecasts

    1 FY2013 Consolidated Results FY2014 Consolidated Forecasts May 12, 2014

  2. Slide 2: Contents

    2 Contents ・ FY2013 Consolidated Results ・ FY2014 Consolidated Forecasts ・ Appendix

  3. Slide 3: FY2013 Consolidated Results

    3 FY2013 Consolidated Results

  4. Slide 4: Scope of Consolidation

    4 Scope of Consolidation - FY2013 Consolidated Results - End of FY2012 End of FY2013 Change Item Notes (A) (B) (B) - (A) Number of Newly Included: 1 consolidated 67 65 -2 Newly Excluded: 3 subsidiaries Number of equity method 25 24 -1 Newly Excluded: 1 affiliates Total 92 89 -3

  5. Slide 5: Material Price Environmental Factors

    5 Environmental Factors - FY2013 Consolidated Results - (Billion Yen) Impacts on FY2012 FY2013 Change Item Consolidated (A) (B) (B) - (A) OP Income Exchange Rate Yen/$ 83.1 100.2 17.1 -0.2 (CIF) $/t 965 940 -25 0.6 Naphtha (Domestic) Yen/KL 57,500 67,300 9,800 (-2.9) Material Price Benzene -0.5 (Ave

  6. Slide 6: Major P/L & B/S Items

    6 Major P/L & B/S Items - FY2013 Consolidated Results - (Billion Yen) FY2012 FY2013 Change Item (A) (B) (B) - (A) Sales 626.0 650.5 24.4 Operating income 29.9 24.4 -5.5 Ordinary income 28.0 18.6 -9.3 Net income 8.2 12.6 4.3 End of FY2012 End of FY2013 Change Item (A) (B) (B) - (A) Total assets 685.8

  7. Slide 7: Non Operating Items

    7 Non Operating Items - FY2013 Consolidated Results - (Billion Yen) FY2012 FY2013 Change Item (A) (B) (B) - (A) Operating income 29.9 24.4 -5.5 Net interest expense -2.6 -2.0 0.5 Equity in earnings of Non operating income unconsolidated subsidiaries 1.2 0.0 -1.2 and affiliated companies Foreign curr

  8. Slide 8: Extraordinary Items

    8 Extraordinary Items - FY2013 Consolidated Results - (Billion Yen) FY2012 FY2013 Change Item (A) (B) (B) - (A) Gain on negative goodwill 0.0 2.8 2.7 Loss on disposal of PP&E -8.4 -0.7 7.6 Loss on impairment -3.1 -0.1 3.0 Loss on related business -2.7 0.0 2.6 Loss on stop of equipment - -1.1 -1.1 Ot

  9. Slide 9: Operating Income - Net Income

    9 Operating Income - Net Income - FY2013 Consolidated Results - (Billion Yen) FY2012 FY2013 Change Item (A) (B) (B) - (A) Operating income 29.9 24.4 -5.5 Non operating item -1.9 -5.7 -3.8 Ordinary income 28.0 18.6 -9.3 Extraordinary item -12.2 0.9 13.1 Income before income tax and minority interest

  10. Slide 10: Sales by Segment

    10 Sales by Segment - FY2013 Consolidated Results - (Billion Yen) FY2012 FY2013 Change Segment Major Factors (A) (B) (B) - (A) Caprolactam chain 9.6 Chemicals & Plastics 219.3 230.5 11.2 Synthetic rubber 1.6 Specialty Chemicals & Specialty products -0.1 Products 61.1 63.1 2.0 Fine chemicals 2.1 Phar

  11. Slide 11: Operating Income by Segment

    11 Operating Income by Segment - FY2013 Consolidated Results - (Billion Yen) FY2012 FY2013 Change Segment Major Factors (A) (B) (B) - (A) Caprolactam chain -4.4 Chemicals & Plastics 5.0 0.8 -4.2 Synthetic rubber 0.2 Specialty Chemicals & Specialty products -2.3 Products 1.2 -0.4 -1.6 Fine chemicals

  12. Slide 12: Analysis of Operating Income

    12 Analysis of Operating Income - FY2013 Consolidated Results - (Billion Yen) Operating Income Segment Change FY2012 FY2013 Sales Fixed Price Others (A) (B) (B) - (A) *1 Volume Cost *2 Chemicals & Plastics 5.0 0.8 -4.2 -5.9 1.7 2.5 -2.5 Specialty Chemicals & Products 1.2 -0.4 -1.6 -2.5 1.1 0.2 -0.4

  13. Slide 13: Consolidated Balance Sheet

    13 Consolidated Balance Sheet - FY2013 Consolidated Results - (Billion Yen) End of FY2012 End of FY2013 Change Item (A) (B) (B) - (A) Current assets 287.3 296.5 9.1 Fixed assets 398.3 404.0 5.6 Total assets 685.8 700.7 14.8 Interest-bearing debts 246.6 245.8 -0.8 Other liabilities 188.4 189.5 1.0 To

  14. Slide 14: Consolidated Statements of Cash Flows

    14 Consolidated Statements of Cash Flows - FY2013 Consolidated Results - (Billion Yen) Item FY2012 FY2013 Income before tax and minority interests 19.6 Depreciation and amortization 32.4 A.Cash flows from operating activities 46.1 37.0 Working capital -1.9, Payment of Tax and others -7.0, Gain on ne

  15. Slide 15: FY2014 Consolidated Forecasts

    15 FY2014 Consolidated Forecasts

  16. Slide 16: Scope of Consolidation - FY2014 Forecasts

    16 Scope of Consolidation - FY2014 Consolidated Forecasts - End of End of Change Item FY2013 FY2014 Notes (A) (B) (B) - (A) Number of consolidated 65 66 +1 Newly Included: 1 subsidiaries Number of equity method 24 26 +2 Newly Included: 2 affiliates Total 89 92 +3

  17. Slide 17: Material Price Environmental Factors - FY14 Forecasts

    17 Environmental Factors - FY14 Consolidated Forecasts - (Billion Yen) Impacts on FY2013 FY2014 Change Item Consolidated (A) (B) (B) - (A) OP Income Exchange Rate Yen/$ 100.2 105.0 4.8 0.0 $/t 940 950 10 (CIF) -0.2 Naphtha (Domestic) (-1.4) Yen/KL 67,300 71,300 4,000 Material Price Benzene (Average

  18. Slide 18: Major P/L & B/S Items - FY14 Forecasts

    18 Major P/L & B/S Items - FY14 Consolidated Forecasts - (Billion Yen) FY2013 FY2014 Change Item (A) (B) (B) - (A) Sales 650.5 670.0 19.5 Operating income 24.4 30.0 5.6 Ordinary income 18.6 24.0 5.4 Net income 12.6 13.5 0.9 End of FY2013 End of FY2014 Change Item (A) (B) (B) - (A) Total assets 700.7

  19. Slide 19: Operating Income - Net Income - FY14 Forecasts

    19 Operating Income - Net Income - FY14 Consolidated Forecasts - (Billion Yen) FY2013 FY2014 Change Item (A) (B) (B) - (A) Operating income 24.4 30.0 5.6 Non operating item -5.7 -6.0 -0.3 Ordinary income 18.6 24.0 5.4 Extraordinary item 0.9 -2.0 -2.9 Income before income tax and minority interest 19

  20. Slide 20: Sales by Segment - FY14 Forecasts

    20 Sales by Segment - FY14 Consolidated Forecasts - (Billion Yen) FY2013 FY2014 Change Segment Major Factors (A) (B) (B) - (A) Caprolactam chain -11.8 Chemicals & Plastics 230.5 227.0 -3.5 Synthetic rubber 8.3 Specialty Chemicals & Specialty products 6.5 63.1 73.0 9.9 Products Fine chemicals 3.4 Pha

  21. Slide 21: Operating Income by Segment - FY14 Forecasts

    21 Operating Income by Segment - FY14 Consolidated Forecasts - (Billion Yen) FY2013 FY2014 Change Segment Major Factors (A) (B) (B) - (A) Caprolactam chain 2.5 Chemicals & Plastics 0.8 4.5 3.7 Synthetic rubber 1.2 Specialty Chemicals & Specialty products 1.0 -0.4 1.0 1.4 Products Fine chemicals 0.4.

  22. Slide 22: Analysis of Operating Income - FY2014 Forecasts

    22 Analysis of Operating Income - FY2014 Consolidated Forecasts - (Billion Yen) Operating Income Segment FY2013 FY2014 Change Sales Fixed Price Others (A) (B) (B) - (A) * Volume Cost Chemicals & Plastics 0.8 4.5 3.7 -3.6 3.0 0.6 3.7 Specialty Chemicals & Products -0.4 1.0 1.4 -5.7 7.1 -1.4 1.4 Pharm

  23. Slide 23: Appendix

    23 Appendix

  24. Slide 24: Management Indices - FY2014 Consolidated Forecasts

    24 Management Indices - FY2014 Consolidated Forecasts - FY2012 FY2013 FY2014 Item Computation Unit (Result) (Result) (Forecast) Net debt Net D/E Ratio Times 0.98 0.89 0.86 /Equity capital Equity capital Equity Ratio % 31.4 34.5 34.7 /Total assets Operating Operating margin Income % 4.8 3.8 4.5 /Sale

  25. Slide 25: R&D Expenses, Capital Investment and Depreciation

    25 R&D Expenses, Capital Investment and Depreciation (Billion Yen) Item FY2012 FY2013 FY2014 Research and development expenses 14.0 13.9 15.0 Capital investment 40.9 36.3 47.0 Depreciation and amortization 31.3 32.4 35.0

  26. Slide 26: Major Items for Capital Expenditure

    26 Major Items for Capital Expenditure Estimeated Segment Subject Place completion date Upgrade of extrusion machinery for nylon Ube, Japan May 2014 Chemicals & compounds Plastics New plant for synthetic rubber (JV) Malaysia November 2014 Additional facilities for producing nylon 6 Spain March 2015

  27. Slide 27: Major Subsidiaries

    27 Major Subsidiaries - FY2013 Consolidated Results - (Billion Yen) Operating Sales income Subsidiaries and Affiliates Business change from FY2013 FY2012 UBE CHEMICALS (ASIA) PUBLIC Manufacture and sales of caprolactam and CO., LTD polyamide resin 45.7 ↓ UBE CHEMICAL EUROPE, S.A. Manufacture and sal

  28. Slide 28: Forward-looking statements disclaimer

    28 This presentation material contains forward-looking statements concerning UBEʼs future plans, strategies, and performance. These forward-looking statements are not historical facts; rather, they represent assumptions and beliefs based on economic, financial, and competitive date currently availab

Ube Industries — FY2013 Earnings Presentation on 6ix